PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-May-2021 Truffle Capital & The Institut Pasteur Create SpikImm to Develop Monoclonal Antibodies as an Innovative Treatment For Covid-19 Businesswire
06-May-2021 Fresenius Medical Care delivers solid first quarter in light of the COVID-19 pandemic, confirms outlook for 2021 Fresenius Medical Care AG & Co. KGaA
06-May-2021 Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers solid first quarter in light of the COVID-19 pandemic, confirms outlook for 2021 Fresenius Medical Care AG & Co. KGaA
06-May-2021 Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US) Lonza Group AG
06-May-2021 Biotest AG: Biotest AG opens 10th plasma collection centre in Hungary Biotest AG
06-May-2021 A New Scientific Publication Highlights the Beneficial Effect of Pherecydes Pharma Phages in Treating a Case of Prosthetic Knee Infection Businesswire
06-May-2021 Deenova Keeps Smashing New Sales Records in 2022 France’s Pharmacy Automation Market Businesswire
05-May-2021 AHF Salutes President Biden for Supporting Vaccine Patents Waiver Businesswire
05-May-2021 ADC Therapeutics’ ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas Businesswire
05-May-2021 BioConsortia Appoints Nancy Vosnidou IP & Portfolio Strategist Businesswire
05-May-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Aterian, Inc. (ATER) f/k/a Mohawk Group Holdings, Inc. on Behalf of Investors Businesswire
05-May-2021 FSD Pharma Announces That ISS Recommends Shareholders Vote for the Company’s Nominees to the Board Using Only the BLUE Proxy Businesswire
05-May-2021 Invacare Reports Results for First Quarter 2021 Businesswire
05-May-2021 Transcat Announces Fourth Quarter and Full Fiscal Year 2021 Conference Call and Webcast Businesswire
05-May-2021 Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights Businesswire
05-May-2021 Glaukos Corporation Announces First Quarter 2021 Financial Results Businesswire
05-May-2021 CVD Equipment to Announce 2021 First Quarter Results Businesswire
05-May-2021 FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma Businesswire
05-May-2021 MorphoSys AG Reports First Quarter 2021 Results MorphoSys AG
05-May-2021 Revelation Biosciences Inc. Announces Results of Phase 1 Clinical Study of REVTx‑99, an Experimental Therapy for the Prevention of Respiratory Viral Infection Businesswire